457 related articles for article (PubMed ID: 22495383)
1. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
2. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Br J Dermatol; 1997 Aug; 137(2):171-8. PubMed ID: 9292062
[TBL] [Abstract][Full Text] [Related]
3. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo Skin: Exploring the Dermal Compartment.
Kovacs D; Bastonini E; Ottaviani M; Cota C; Migliano E; Dell'Anna ML; Picardo M
J Invest Dermatol; 2018 Feb; 138(2):394-404. PubMed ID: 29024688
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
Seleit I; Bakry OA; Abdou AG; Dawoud NM
Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
7. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
8. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
9. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
10. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
11. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
12. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus.
Lai LG; Xu AE
Skin Res Technol; 2011 Nov; 17(4):404-10. PubMed ID: 21429011
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo.
Hassan AS; Kohil MM; Sayed SSE; Mahmoud SB
Arch Dermatol Res; 2021 Aug; 313(6):453-460. PubMed ID: 32785835
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic features in vitiligo.
Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
[TBL] [Abstract][Full Text] [Related]
15. Melanin and melanosome complexes in long standing stable vitiligo--an ultrastructural study.
Bartosik J; Wulf HC; Kobayasi T
Eur J Dermatol; 1998 Mar; 8(2):95-7. PubMed ID: 9649719
[TBL] [Abstract][Full Text] [Related]
16. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
[TBL] [Abstract][Full Text] [Related]
17. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis.
Elsherif R; Mahmoud WA; Mohamed RR
Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959
[TBL] [Abstract][Full Text] [Related]
18. Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease.
Esmat SM; Hadidi HHE; Hegazy RA; Gawdat HI; Tawdy AM; Fawzy MM; AbdelHalim DM; Sultan OS; Shaker OG
Arch Dermatol Res; 2018 Jul; 310(5):425-430. PubMed ID: 29605863
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 and its A and B receptors: are they possibly involved in vitiligo?
Aly DG; Salem SA; Abdel-Hamid MF; Youssef NS; El Shaer MA
Acta Dermatovenerol Croat; 2013; 21(1):12-8. PubMed ID: 23683481
[TBL] [Abstract][Full Text] [Related]
20. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
Kim NH; Lee AY
Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]